HomeInsightsStock Comparison

Megasoft Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Megasoft Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 16, 2025

Key Highlights

  • The Latest Trading Price of Megasoft Ltd is ₹ 69 as of 16 May 11:40.
  • The P/E Ratio of Megasoft Ltd changed from 31.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 53.2 on March 2024 . This represents a CAGR of 10.29% over 5 years.
  • The Market Cap of Megasoft Ltd changed from ₹ 22.27 crore on March 2020 to ₹ 659.06 crore on March 2024 . This represents a CAGR of 96.90% over 5 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 88030 crore on March 2024 . This represents a CAGR of 21.42% over 5 years.
  • The revenue of Megasoft Ltd for the Dec '24 is ₹ 12.73 crore as compare to the Sep '24 revenue of ₹ 8.56 crore. This represent the growth of 48.71% The revenue of Torrent Pharmaceuticals Ltd for the Dec '24 is ₹ 2842 crore as compare to the Sep '24 revenue of ₹ 2873 crore. This represent the decline of -1.08%.
  • The ebitda of Megasoft Ltd for the Dec '24 is ₹ 9.4 crore as compare to the Sep '24 ebitda of ₹ 6.43 crore. This represent the growth of 46.19% The ebitda of Torrent Pharmaceuticals Ltd for the Dec '24 is ₹ 947 crore as compare to the Sep '24 ebitda of ₹ 923 crore. This represent the growth of 2.6%.
  • The net profit of Megasoft Ltd changed from ₹ 3.25 crore to ₹ 3.59 crore over 7 quarters. This represents a CAGR of 5.85% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 503 crore over 7 quarters. This represents a CAGR of 17.73% .
  • The Dividend Payout of Megasoft Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 69.83 % on March 2024 . This represents a CAGR of 3.89% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Megasoft Ltd

  • Megasoft Limited is a transnational intellectual property-driven, product-based technology company, which incorporated on 29th June 1999 and focused its expertise on the telecom sector.
  • The Company provides telecom services throughout the globe under XIUS-bcgi and also offers Outsourcing, Off-shoring and back-office services to other product companies in the areas of Product Life Cycle Management (PLM) & and Application Development & Maintenance Services (ADMS) under the name and style of BlueAlly.
  • Megasoft has strong product engineering and product development capacities with Capability Maturity Model (CMM) Level 5 certification and has operations in India, U.S., UK, Singapore, Malaysia and Germany. The Company had merged with Indus e solutions a public listed company in the year of 2000.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.

Megasoft Ltd News Hub

News

Megasoft to hold board meeting

Megasoft will hold a meeting of the Board of Directors of the Company on 14 February 2025....

Read more

11 Feb 2025 11:19

News

Megasoft schedules board meeting

Megasoft will hold a meeting of the Board of Directors of the Company on 11 November 2024 ...

Read more

07 Nov 2024 14:15

News

Megasoft to conduct AGM

Megasoft announced that the Annual General Meeting (AGM) of the company will be held on 27...

Read more

06 Sep 2024 16:38

News

Megasoft schedules AGM

Megasoft announced that the Annual General Meeting (AGM) of the company will be held on 27...

Read more

06 Sep 2024 17:41

News

Megasoft Ltd leads losers in 'B' group

Nucleus Software Exports Ltd, Ola Electric Mobility Ltd, Atam Valves Ltd and Akums Drugs &...

Read more

22 Aug 2024 14:45

News

Megasoft revises board meeting date

Megasoft has revised the meeting of the Board of Directors which was scheduled to be held ...

Read more

08 Aug 2024 11:02

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals to conduct board meeting

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20...

Read more

14 May 2025 14:06

News

Torrent Pharmaceuticals announces resignation of ED (Strategic Planning)

Torrent Pharmaceuticals announced that Pranav Mehta, Executive Director (Strategic Plannin...

Read more

27 Feb 2025 18:47

News

Torrent Pharmaceuticals Ltd rises for third consecutive session

Torrent Pharmaceuticals Ltd gained for a third straight session today. The stock is quotin...

Read more

07 Feb 2025 13:05

News

Torrent Pharmaceuticals Ltd slips for fifth straight session

Torrent Pharmaceuticals Ltd is down for a fifth straight session today. The stock is quoti...

Read more

04 Feb 2025 13:35

News

Torrent Pharma gains after Q3 PAT rises 14% YoY to Rs 503 cr

Revenue from operations grew 2.6% year on year (YoY) to Rs 2,762 crore in the quarter ende...

Read more

27 Jan 2025 14:33

News

Board of Torrent Pharmaceuticals recommends interim dividend

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

24 Jan 2025 17:25

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Megasoft Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Megasoft Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Megasoft Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Megasoft Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Megasoft Ltd is 516 Cr while Market cap of Torrent Pharmaceuticals Ltd is 110,516 Cr

What are the key factors driving the stock performance of Megasoft Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Megasoft Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Megasoft Ltd and Torrent Pharmaceuticals Ltd?

As of May 16, 2025, the Megasoft Ltd stock price is INR ₹70.01. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3265.55.

How do dividend payouts of Megasoft Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Megasoft Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions